First mRNA Flu Vaccine Receives FDA Approval

Why it matters locally: The approval of the first mRNA flu vaccine by the FDA could significantly impact public health efforts in Oregon, potentially influencing vaccine distribution strategies and public health campaigns by agencies like the Oregon Health Authority.

---

The Food and Drug Administration (FDA) approved an mRNA-based flu vaccine for use in the upcoming flu season. Moderna, the vaccine's developer, created this new immunization technology. This approval represents the first time an mRNA flu vaccine has received authorization from the FDA. The vaccine will become available to the public in time for the next seasonal influenza period.